Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of September 30, 2023 and December 31, 2022:

 

    September 30, 2023     December 31, 2022  
Lab supplies   $ 1,093     $ 1,224  
Prepaid expenses     440       390  
Funds in escrow     -       500  
Other     43       180  
Total other current assets   $ 1,576     $ 2,294  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

    2023     2022     2023     2022  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2023     2022     2023     2022  
Basic weighted average number of common shares     4,319       4,242       4,313       4,227  
Potential dilutive effect of stock-based awards     -       -       42       -  
Diluted weighted average number of common shares     4,319       4,242       4,355       4,227  

SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    2023     2022     2023     2022  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2023     2022     2023     2022  
Options     469       578       394       578  
Restricted stock units (RSUs)     277       340       277       340  
Warrants     -       54       -       54  
Anti-dilutive securities     746       972       671       972